Mast cells: A possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable Bowel syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 10, 1998, Pages 980-989

  Gui, Xian Yong ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Functional bowel disorder; Hypersensitivity; Irritable Bowel syndrome; Irritable gut; Mast cell

Indexed keywords

DISEASE ASSOCIATION; ENTERITIS; FOOD ALLERGY; HUMAN; IRRITABLE COLON; MENTAL STRESS; PATHOGENESIS; PERITONEUM MAST CELL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECOND MESSENGER;

EID: 0031769345     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00558.x     Document Type: Review

References (149)

1. Oddson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand. J. Gastroenterol. 1978; 13: 409-16.
2. Kellow JE, Phillips SF, Miller LJ. Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988; 29: 1236-43.
3. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: 1885-93.
4. Cook IJ, Eden A van, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93: 727-33.
5. Whitehead WE, Holtkotten B, Enck P. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92.
6. Kellow JE, Eckersley CM, Jones MP. Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology 1991; 101: 1621-7.
7. Mertz H, Naliboff B, Munakata J. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
8. Read NW. Irritable bowel syndrome (IBS). Definition and pathophysiology. Scand. J. Gastroenterol. 1987; 22 (Suppl. 130): 1-7.
9. White A, Upton A, Collins SM. Is irritable bowel syndrome the asthma of the gut? Gastroenterology 1988; 94: A494.
10. Drossman DA, McKee DC, Sandler RS et al. Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
11. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease. Am. Psychiatry 1990; 147: 1656-61.
12. Williams CL, Villar RG, Peterson JM. Stress-induced changes in intestinal transit in the rat: A model for irritable bowel syndrome. Gastroenterology 1988; 94: 611-21.
13. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonie sensation in the human transverse and sigmoid colon. Gastroenterology 1995; 109: 1772-80.
14. Metivier S, Delvaux M, Louvel D et al. Stress could influence sensory thresholds to rectal distension through an increase in rectal tone. Neurogastroenterol. Motility 1996; 8: 182.
15. Ayres RCS, Robertson DAF, Naylor K, Smith CL. Stress and oesophageal motility in normal subjects and patients with irritable bowel syndrome. Gut 1989; 30: 1540-3.
16. Fukudo S, Suzuki J. Colonic motility, autonomic function and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J. Exp. Med. 1987; 151: 373-85.
17. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut 1987; 28: 423-5.
18. Shaw G, Srivastava ED, Sadlier M, Swann P, James JY, Rhodes J. Stress management for irritable bowel syndrome: A controlled trial. Digestion 1991; 50: 36-42.
19. Blanchard EB, Schwarz SP, Suls JM et al. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behav. Res. Ther. 1992; 30: 175-89.
20. Thompson WG. Irritable bowel syndrome: Prevalence, prognosis and consequences. Can. Med. Assoc. J. 1986; 134: 111-13.
21. Jones R. Investigating lower bowel symptoms in general practice. BMJ 1992; 304: 87-90.
22. Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 1992; 102: 1962-7.
23. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
24. McKendrick MW, Read NW. Irritable bowel syndrome. Post Salmonella infection. J. Infect. 1994; 29: 1.
25. Khan I, Collins SM. Is there an inflammatory basis for a subset of patients presenting with diarrhoea in the irritable bowel syndrome. Gastroenterology 1994; 106: A523.
26. Munzer D, Eyad C. Spastic colitis and irritable bowel syndrome:Which expression is prevalent? A review of 120 cases. Trop. Gastroenterol. 1992; 13: 27-35.
27. Salzmann JL, Peltier-Koch F, Bloch F, Petite JP, Camilleri JP. Methods in laboratory investigation: Morphometric study of colonic biopsies: A new method of estimating inflammatory diseases. Lab. Invest. 1992; 60: 847-51.
28. Lee E, Schiller LR, Fordtran JS. Quantification of colonie lamina propria cells by means of a morphometric point-counting method. Gastroenterology 1988; 94: 409-18.
29. Nazeeri MN, Shea-Donohue T, Pineiro-Carrero VM. The role of nitric oxide in tachykinin smooth muscle response in acute and chronic ileitis in rats. Dig. Dis. Sci. 1996; 41: A86.
30. Bossone C, Hosseini J, Matin D, Pineiro-Carrero VM, Shea-Donohue T. Altered smooth muscle responses to tachykinins in reinflamed versus acutely inflamed rat colon. Dig. Dis. Sci. 1996; 41: A80.
31. Jadcherla SR, Sarna SK. Inflammation modulates the colonie contractile response to muscarinic receptor activation. Dig. Dis. Sci. 1996; 41: A71.
32. Conklin JL, Anuras S. Effects of prostaglandins E2 and F2 alpha on electromyogram of cat colon in vitro. Dig. Dis. Sci. 1996; 41: 720-6.
33. Bielefeldt K, Conklin JL. Tumor necrosis factor alters calcium homeostasis and redox state in intestinal smooth muscle cells. Dig. Dis. Sci. 1996; 41: A71.
34. Collins SM, Hurst SM, Matin C. Effect of inflammation on enteric nerves: Cytokine-induced changes in neurotransmitter content and release. Ann. NY Acad. Sci. 1990; 664: 415-24.
35. Vallance BA, Blennerhasseff PA, Collins SM. Murine trichinosis: A model of post-infective smooth muscle dysfunction. Gastroenterology 1994; 106: A582.
36. Ruhl A, Hurst S, Collins SM. Synergism between interleukins 1 beta and 6 on noradrenergic nerves in rat myenteric plexus. Gastroenterology 1994; 107: 993-1001.
37. Jacobson K, McHugh K, Collins SM. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995; 109: 718-22.
38. Khan I, Collins SM. Expression of cytokines in the Iongitudinal muscle myenteric plexus of the inflamed intestine of rat. Gastroenterology 1994; 107: 691-700.
39. Valentine JF, Tannahill CL, Stevenot SA, Sallustio JE, Nick HS, Eaker EY. Colitis and interleukin 1 beta up-regulate inducible nitric oxide synthase and superoxide dismutase in rat myenteric neurons. Gastroenterology 1996; 111: 56-64.
40. Rao SSC, Read NW, Davison PA, Bannister JJ, Holdsworth CD. Anorectal sensitivity and responses to rectal distension in patients with ulcerative colitis. Gastroenterology 1987; 93: 1270-5.
41. Rao SSC, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut 1988; 29: 342-5.
42. Morteau O, Hachet T, Caussette M, Bueno L. Experimental colitis alters viscera motor response to colorectal distension in awake rats. Dig. Dis. Sci. 1994; 39: 1239-48.
43. Chang L, Munakata J, An K et al. Evidence for the activation of endogenous pain modulation system in ulcerative colitis (UC). Gastroenterology 1996; 110: A645.
44. Smith MA, Youngs GR, Finn R. Food intolerance, atopy and irritable bowel syndrome. Lancet 1985; ii: 1064 (letter).
45. Lessof MH. Food intolerance. Scand. J. Gastroenterol. 1985; 109: 117-21.
46. Zwetchkenbaum JF, Burakoff R. Food allergy and the irritable bowel syndrome. Am. J. Gastroenterol. 1988; 83: 901-4.
47. Mullin GE. Food allergy and irritable bowel syndrome. JAMA 1991; 265: 1736.
48. Schmidt M, Floch MH. Food hypersensitivity and the irritable bowel syndrome. Am. J. Gastroenterol. 1992; 87: 18.
49. Lewis PJ. Management of the irritable bowel syndrome. Food intolerance may play a part. BMJ 1995; 310: 1067.
50. Allun Jone V, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: A major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; i: 115-17.
51. Addolorato G, Gasbarrini G, Marsigli L, Stefanini GF. Irritable bowel syndrome and food allergy: An association via anxiety-depression? Gastroenterology 1996; 111: 833.
52. Barau E, Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 1990; 11: 72-7.
53. Malatesta MG, Forlani G, Falcucci M et al. Mouth to caecum transit time (MCTT) is accelerated after oral food antigen in patients with irritable bowel syndrome (IBS). Gastroenterology 1996; 110: A712.
54. Bischoff SC. Mucosal allergy: Role of mast cells and eosinophil granulocytes in the gut. Bailliere's Clin. Gastroenterol. 1996; 10: 443-59.
55. Pelikan Z, Pelikan-Filipek M. The late asthmatic response to allergen challenge. Part II. Ann. Allergy 1986; 56: 421-35.
56. Petitpierre M, Gumowski P, Girard JP. Irritable bowel syndrome and hypersensitivity to food. Ann. Allergy 1985; 54: 538-40.
57. Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: Basic mechanism of pathophysiology. Gastroenterology 1992; 103: 1075-95.
58. Shanahan F. Food allergy: Fact, fiction and fatality. Gastroenterology 1993; 104: 1229-31.
59. O'Keefe SJD. Nutrition and gastrointestinal disease. Scand. J. Gastroenterol. 1996; 31 (Suppl. 220): 56.
60. White AM, Stevens WH, Upton AR, O'Byrne PM, Collins SM. Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome. Gastroenterology 1991; 100: 68-74.
61. Wallaert B, Desreumaux P, Copin MC et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/ macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J. Exp. Med. 1995; 182: 1897-904.
62. Barnes RM, Johnson PM, Harvey MM, Blears J, Finn R. Human serum antibodies reactive with dietary proteins. IgG subclass distribution. Int. Arch. Allerg. Immunol. 1988; 87: 184-8.
63. McHugh K, Weingarten HP, Khan I, Riddell R, Collins SM. Stress-induced exacerbation of experimental colitis in the rat. Gastroenterology 1993; 104: A1051.
64. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: The interaction of disease activity with psychosocial function. Am. J. Gastroenterol. 1995; 90: 1450-4.
65. Levenstein S, Prantera C, Varvo V. Psychological stress and disease activity in ulcerative colitis: A multidimensional cross-sectional study. Am. J. Gastroenterol. 1994; 89: 1219-25.
66. Namimatsu A, Go K, Hata T. Nasal mucosal hypersensitivity in guinea pigs intermittently exposed to cold. Int. Arch. Allerg. Immunol. 1991; 96: 107-12.
67. Namimatsu A, Go K, Hata T. Regulatory effect of neurotropin on nasal mucosal hypersensitivity in guinea pigs caused by SART (intermittent exposure to cold) stress. Jpn J. Pharmacol. 1992; 59: 371-7.
68. Hu WY, Wingate DL. In sensitised rats, postprandial motor dysfunction is induced by stress and challenge. Gastroenterology 1996; 110: A682.
69. Djuric VJ, Overstreet DH, Bienenstock J, Perdue MH. Immediate hypersensitivity in the Flinder rat: Further evidence for a possible link between susceptibility to allergies and depression. Brain Behav. Immun. 1995; 9: 196-206.
70. Saunders PR, Kosecka U, McKay DM, Perdue MH. Acute stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am. J. Physiol. 1994; 267: G794-9.
71. Havima IT, Viinamaki H, Naukkarinen A et al. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychother. Psychosoma 1993; 60: 168-76.
72. Bugajski AJ, Chlap Z, Gadek-Michalska, Bugajski J. Effect of isolation stress on brain mast cells and brain histamine levels in rats. Agents Actions 1994; 41: C75.
73. Castagliuolo I, Lamont JT, Qiu B. Acute stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells. Am. J. Physiol. 1996; 271: G884-92.
74. Fargeas MJ, Theodourou V, More J, Wal JM, Fioramonti J, Bueno L. Boosted systemic immune and local responsiveness after intestinal inflammation in orally sensitized guinea pigs. Gastroenterology 1995; 109: 53-62.
75. Theoharides TC, Spanos C, Pang X et al. Stress-induced intracranial mast cell degranulation: A corticotropin releasing hormone-mediated effect. Endocrinology 1995; 136: 5745-50.
76. Reimann HT, Lewin J, Schmidt U, Wendt P, Blueml G. Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins 1987; 33 (Suppl.): 105-16.
77. Wang D, Ogle CW. Chronic parenterally administered nicotine and stress-or ethanol-induced gastric mucosal damage in rats. Eur. J. Pharmacol. 1995; 292: 157-62.
78. Ogle CW, Hui SC. The influence of peripheral or central administration of ondanstron on stress-induced gastric ulceration in rats. Experientia 1995; 51: 786-9.
79. 4 antagonists of stress-induced colonic dysfunction and visceral pain in the rat. Gastroenterology 1996; 110: A735.
80. 3 receptor in corticotropin-releasing hormone (CRH)-induced defecation in rats. Gastroenterology 1996; 110: A719.
81. Gue M, Del Rio-Lacheze C, Fioramonti J, Bueno L. Stress-induced visceral hypersensitiviry in rats: Involvement of mast cell degranulation. Neurogastroenterol. Motility 1996; 8: 175.
82. Castagliulo I, Leeman SE, Bartolak-Suki E et al. A neurotensin antagonist, SR 48692, inhibits colonie responses to immobilization stress in rats. Proc. Natl Acad. Sci. USA 1996; 93: 1261-5.
83. King T, Biddle W, Bhatia P, Moore J, Miner PB Jr. Colonie mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig. Dis. Sci. 1992; 37: 490-5.
84. Bischoff SC, Wedemeyer J, Herrmann A. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996; 28: 1-13.
85. McNeil HP. The mast cell and inflammation. Aust. NZ J. Med. 1996; 26: 216-25.
86. Fox CC, Lichehtenstein LM, Roche JK. Intestinal mast cell response in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins. Dig. Dis. Sci. 1993; 38: 1105-12.
87. Ruhl A, Berezin I, Collins SM. Involvement of eicosanoids and macrophage-like cells in cytokine-mediated changes in rat myenteric nerves. Gastroenterology 1995; 109: 1852-62.
88. Scott RB, Diamant SC, Gall DG. Motility effects of intestinal anaphylaxis in the rat. Am. J. Physiol. 1988; 255: G505-11.
89. Fargeas MJ, Theodourou V, Fioramonti J, Bueno L. Relationship between mast cell degranulation and jejunal myoelectric alterations in intestinal anaphylaxis in rats. Gastroenterology 1992; 102: 157-62.
90. Oliver MR, Tan DT, Scott RB. Intestinal anaphylaxis: mediation of the response of colonic longitudinal muscle in rat. Am. J. Physiol. 1995; 268: G764-71.
91. Oliver MR, Tan DTM, Scott RB. Colonie motor response to Ig-E mediated mast cell degranulation in the Hooded-Lister rat. Neurogastroenterol. Motility 1996; 8: 121-30.
92. Wang L, Stanisz AM, Wershil BK, Galli SJ, Perdue MH. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am. J. Physiol. 1995; 269: G85-92.
93. Oliver MR, Tan DTM, Kirk DR, Rioux KP, Scott RB. Mast cell activation causes local and remote gastrointestinal motor disturbances through the action of mediators on neural pathways. Gastroenterology 1996; 110: A726.
94. Bueno L, Fargeas MJ, Theodourou V, Fioramonti J. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats. Eur. J. Pharmacol. 1991; 192: 263-9.
95. Fargeas MJ, Theodourou V, Fioramonti J, Bueno L. Relationship between mast cell degranulation and jejunal myoelectric alterations in intestinal anaphylaxis in rats. Gastroenterology 1992; 102: 157-62.
96. 3 receptors and afferent fibers in the effects of mast cell degranulation on colonie motility in rats. Gastroenterology 1994; 107: 976-84.
97. 2A receptors on the longitudinal and circular muscle of the dog colon. Dig. Dis. Sci. 1996; 41: A50.
98. Eastwood C, Grundy D. Effects of antigenic challenge upon intestinal afferent discharge. Neurogastroenterol. Motility 1996; 8: 170.
99. Malaviya R, Ross E, Jackschik BA, Abraham SN. Mast cell degranulation induced by type I fimbriated Escherichia coli in mice. J. Clin. Invest. 1994; 93: 1645-53.
100. Mohammadi M, Redline R, Nedrud J, Czinn S. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect. Immun. 1996; 64: 238-45.
101. Abraham SN, Sun D, Dale JB, Beachey EH. Conservation of the D-mannose-adhesion protein among type I fimbriated members of the family Enterobacteriaceae. Nature 1988; 336: 682-4.
102. Newson B, Dahlstrom A, Enerback L, Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience 1983; 10: 565.
103. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989; 97: 575-85.
104. Stead RH. Innervation of mucosal immune cells in the gastrointestinal tract. Reg. Immunol. 1992; 4: 91-9.
105. Frieling T, Cooke HJ, Wood JD. Histamine receptors on submucous neurons in guinea pig colon. Am. J. Physiol. 1993; 264: G74-80.
106. Ottaway CA. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. North Am. 1991; 20: 511-29.
107. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol. Today 1994; 15: 533-8.
108. Gay J, Garcia-Villar R, Carriere JL, Martinolle JP, Fioramonti J, Bueno L. Role of mast cells in contractile hypersensitivity to I.-NAMA induced by substance P in guinea pig ileum. Neurogastroenterol. Motility 1996; 8: 173.
109. Eutamene H, Theodourou V, Fioramonti J, Bueno L. Rectal distension (RD) evoked water colonie hypersecretion is mediated by a neuro-immune pathway: Involvement of interleukine-1β. Neurogastroenterol. Motility 1996; 8: 171.
110. Juanola C, Mourelle M, Vergara P. Mast cells mediated endogenous CCK regulation of small intestine motor patterns. Neurogastroenterol. Motility 1996; 8: 177.
111. Nemeth PR, Ort CA, Wood JD. Intracellular study of effects of histamine on electrical behaviour of myenteric neurones in guinea-pig small intestine. J. Physiol. 1984; 355: 411-25.
112. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/WV mice by bone marrow transplantation. J. Clin. Invest. 1991; 87: 687-93.
113. Frieling T, Palmer JM, Cooke HJ, Wood JD. Neuroimmune communication in the submucous plexus of guinea pig colon after infection with Trichinella spiralis. Gastroenterology 1994; 107: 1602-9.
114. 3 receptors. Med. Res. Rev. 1990; 10: 441-75.
115. Maggi CA. The pharmacology of the efferent function of sensory nerves. J. Auton. Pharmacol. 1991; 11: 173-208.
116. Akoev GN, Filippova LV, Sherman NO. Mast cell mediators excite the afferents of cat small intestine. Neuroscience 1996; 71: 1163-6.
117. Tamura K, Wood JD. Effects of prolonged exposure to histamine on guinea pig intestinal neurons. Dig. Dis. Sci. 1992; 37: 1084.
118. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995; 373: 347-9.
119. Maeda H, Yamagata A, Nishikawa S, Yoshinaga K, Kobayashi S, Nishi K, Nishikawa S. Requirement of c-kit for development of intestinal pacemaker system. Development 1992; 116: 369-75.
120. Ward SM, Burns AJ, Torihashi S, Harney SC, Sanders KM. Impaired development of interstitial cells and intestinal electrical rhythmicity in steel mutants. Am. J. Physiol. 1995; 269: C1577-85.
121. Bischoff SC, Schwengberg S, Wordelmann K, Weimann A, Raab R, Manns MP. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996; 38: 104-14.
122. Russel M, Dark KA, Cummins RW et al. Learned histamine release. Science 1984; 225: 733.
123. MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989; 243: 83-5.
124. Gottward TP, Hewlett BR, Lhotak S, Stead RH. Electrical stimulation of the cervical vagus nerve activates mast cells in the rat jejunal mucosa. Gastroenterology 1994; 106: A691.
125. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig. Dis. Sci. 1993; 38: 1590-5.
126. Chaudhary NA, Truelove SC. The irritable colon syndrome. Q. J. Med. 1962; 123: 307-22.
127. Hiatt RB, Katz J. Mast cells in inflammatory conditions of the gastrointestinal tract. Am. J. Gastroenterol. 1962; 37: 541-5.
128. Stefanini GF, Bazzocchi G, Prati E, Lanfranchi GA, Gasbarrini G. Efficacy of oral disodium cromoglycate in patients with irritable bowel syndrome and positive skin prick tests to foods. Lancet 1986; 1: 207-8 (letter).
129. Stefanini GF, Prati E, Albini MC et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: An open study on 101 subjects with diarrheic type. Am. J. Gastroenterol. 1992; 87: 55-7.
130. Stefanini GF, Saggioro A, Alvisi V et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand. J. Gastroenterol. 1995; 30: 535-44.
131. 3 receptor antagonist, in patients with irritable bowel syndrome. Gut 1990; 31: A1174.
132. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondanstron as treatment for diarrhea-predominant irritable bowel syndrome: A pilot study. Mayo Clin. Proc. 1992; 67: 732-8.
133. 3 antagonism (Ondanstron). Digestion 1996; 57: 478-83.
134. Kachur JF, Allbee WE, Gaginella TS. Antihistaminic and antimuscarinic effects of amitriptyline on guinea pig ileal electrolyte transport and muscle contractility in vitro. J. Pharmacol. Exp. Ther. 1988; 245: 455-9.
135. Gorard DA, Libby GW, Farthing MJ. Effect of tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome. Dig. Dis. Sci. 1995; 40: 86-95.
136. Libel R, Biddle WL, Miner Jr PB. Evaluation of anorectal physiology in patients with increased mast cells. Dig. Dis. Sci. 1993; 38: 877-81.
137. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: A survey of 374 patients. J. Urol. 1993; 149: 465.
138. Theoharides TC, Sant GR, El-Mansoury M, Letourneau R, Ucci AA Jr, Meares EM Jr. Activation of bladder mast cells in interstitial cystitis: A light and electron microscopic study. J. Urol. 1995; 153: 629-36.
139. Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br. J. Urol. 1995; 75: 154-61.
140. Pang X, Boucher W, Triadafilopoulos G, Sant GR, Theoharides TC. Mast cell and substance P positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996; 47: 436-8.
141. Rosin RD, Griffiths T, Sofras F, James DC, Edwards L. Interstitial cystitis. Br. J. Urol. 1979; 51: 524-7.
142. Hanno PM, Buehler J, Wein AJ. Use of amitriptyline in the treatment of interstitial cystitis. J. Urol. 1989; 141: 846.
143. Whorwell PJ, Lupton EW, Erduran D, Wilson K. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut 1986; 27: 1014-17.
144. Terruzzi V, Magatti F, Quadri G et al. Bladder dysfunction and irritable bowel syndrome. Am. J. Gastroenterol. 1992; 87: 1231-2.
145. Gibbs CJ, Courts II, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984; 39: 833.
146. Wormald PJ. Age-sex incidence in symptomatic allergies: An excess of females in the child-bearing years. J. Hyg. 1978; 79: 39-42.
147. Whitehead WE, Cheskin LJ, Heller BR et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology 1990; 98: 1485-9.
148. Vliagoftis H, Dimitriadou V, Boucher W et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int. Arch. Allerg. Immunol. 1992; 98: 398.
149. Galli SJ. New concepts about the mast cell. New Engl. J. Med. 1993; 328: 257-65.